-
1
-
-
36549001139
-
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States
-
17904915 10.1016/j.cgh.2007.07.012
-
Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 1424-1429
-
-
Kappelman, M.D.1
Rifas-Shiman, S.L.2
Kleinman, K.3
-
2
-
-
62649107261
-
Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: An in vitro study
-
19309553 1:CAS:528:DC%2BD1MXkt1ensb0%3D
-
Ardizzone S, Cassinotti A, Trabattoni D, et al. Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol. 2009;22:63-71.
-
(2009)
Int J Immunopathol Pharmacol
, vol.22
, pp. 63-71
-
-
Ardizzone, S.1
Cassinotti, A.2
Trabattoni, D.3
-
3
-
-
33744826596
-
Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel disease
-
16563470 10.1016/j.pbiomolbio.2006.02.020 1:CAS:528:DC%2BD28XlsFKrsbg%3D
-
Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol. 2006;92:60-64.
-
(2006)
Prog Biophys Mol Biol
, vol.92
, pp. 60-64
-
-
Cantorna, M.T.1
-
4
-
-
23344440711
-
Mechanisms of disease: Vitamin D and inflammatory bowel disease
-
16265284 10.1038/ncpgasthep0215 1:CAS:528:DC%2BD2MXntFSkurw%3D
-
Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:308-315.
-
(2005)
Nat Clin Pract Gastroenterol Hepatol
, vol.2
, pp. 308-315
-
-
Lim, W.C.1
Hanauer, S.B.2
Li, Y.C.3
-
5
-
-
79251550435
-
Why do T cells express the vitamin D receptor?
-
21114675 10.1111/j.1749-6632.2010.05823.x 1:CAS:528:DC%2BC3MXislymtL4%3D
-
Cantorna MT. Why do T cells express the vitamin D receptor? Ann NY Acad Sci. 2011;1217:77-82.
-
(2011)
Ann NY Acad Sci
, vol.1217
, pp. 77-82
-
-
Cantorna, M.T.1
-
6
-
-
77949712412
-
Vitamin D and the immune system
-
20080911 10.3899/jrheum.090797 1:CAS:528:DC%2BC3cXksVKgsrw%3D
-
Maruotti N, Cantatore FP. Vitamin D and the immune system. J Rheumatol. 2010;37:491-495.
-
(2010)
J Rheumatol
, vol.37
, pp. 491-495
-
-
Maruotti, N.1
Cantatore, F.P.2
-
7
-
-
0034037044
-
Vitamin D and autoimmunity: Is vitamin D status an environmental factor affecting autoimmune disease prevalence?
-
10719834 10.1046/j.1525-1373.2000.22333.x 1:CAS:528:DC%2BD3cXksVKqurg%3D
-
Cantorna MT, Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med. 2000;223:230-233.
-
(2000)
Proc Soc Exp Biol Med
, vol.223
, pp. 230-233
-
-
Cantorna, M.T.1
-
8
-
-
48749115601
-
The complex role of vitamin D in autoimmune diseases
-
18510590 10.1111/j.1365-3083.2008.02127.x 1:CAS:528:DC%2BD1cXhtFajtrnN
-
Szodoray P, Nakken B, Gaal J, et al. The complex role of vitamin D in autoimmune diseases. Scand J Immunol. 2008;68:261-269.
-
(2008)
Scand J Immunol
, vol.68
, pp. 261-269
-
-
Szodoray, P.1
Nakken, B.2
Gaal, J.3
-
9
-
-
10044281540
-
Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence
-
1:CAS:528:DC%2BD2cXhtVOmtb7J
-
Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004;229:1136-1142.
-
(2004)
Exp Biol Med (Maywood)
, vol.229
, pp. 1136-1142
-
-
Cantorna, M.T.1
Mahon, B.D.2
-
10
-
-
33751584448
-
Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease
-
17119391 10.1097/01.mib.0000236929.74040.b0
-
Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006;12:1162-1174.
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 1162-1174
-
-
Pappa, H.M.1
Grand, R.J.2
Gordon, C.M.3
-
11
-
-
84857533986
-
Higher predicted vitamin D status is associated with reduced risk of Crohn's disease
-
22155183 10.1053/j.gastro.2011.11.040 1:CAS:528:DC%2BC38XivFyjsL8%3D
-
Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012;142:482-489.
-
(2012)
Gastroenterology
, vol.142
, pp. 482-489
-
-
Ananthakrishnan, A.N.1
Khalili, H.2
Higuchi, L.M.3
-
12
-
-
77954324863
-
Clinical trial: Vitamin D3 treatment in Crohn's disease - A randomized double-blind placebo-controlled study
-
20491740 10.1111/j.1365-2036.2010.04355.x 1:STN:280: DC%2BC3cnnvVSguw%3D%3D
-
Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010;32:377-383.
-
(2010)
Aliment Pharmacol Ther
, vol.32
, pp. 377-383
-
-
Jorgensen, S.P.1
Agnholt, J.2
Glerup, H.3
-
13
-
-
79955653072
-
Vitamin D deficiency in patients with inflammatory bowel disease: Association with disease activity and quality of life
-
21527593 10.1177/0148607110381267 1:CAS:528:DC%2BC3MXntlyhsb8%3D
-
Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011;35:308-316.
-
(2011)
JPEN J Parenter Enteral Nutr
, vol.35
, pp. 308-316
-
-
Ulitsky, A.1
Ananthakrishnan, A.N.2
Naik, A.3
-
14
-
-
59849104111
-
Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis
-
18623174 10.1002/ibd.20520
-
Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660-1666.
-
(2008)
Inflamm Bowel Dis
, vol.14
, pp. 1660-1666
-
-
Lewis, J.D.1
Chuai, S.2
Nessel, L.3
-
15
-
-
16544367410
-
Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system
-
15585793 1:CAS:528:DC%2BD2cXhtFaisrjO
-
Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80:1717S-1720S.
-
(2004)
Am J Clin Nutr
, vol.80
-
-
Cantorna, M.T.1
Zhu, Y.2
Froicu, M.3
-
16
-
-
0345724737
-
Vitamin D deficiency: What a pain it is
-
14661673 10.4065/78.12.1457
-
Holick MF. Vitamin D deficiency: what a pain it is. Mayo Clin Proc. 2003;78:1457-1459.
-
(2003)
Mayo Clin Proc
, vol.78
, pp. 1457-1459
-
-
Holick, M.F.1
-
17
-
-
0033745125
-
1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease
-
11053501 1:CAS:528:DC%2BD3cXnvVOlsbY%3D
-
Cantorna MT, Munsick C, Bemiss C, et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000;130:2648-2652.
-
(2000)
J Nutr
, vol.130
, pp. 2648-2652
-
-
Cantorna, M.T.1
Munsick, C.2
Bemiss, C.3
-
18
-
-
11444264875
-
The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients
-
15684874 10.1089/gte.2004.8.417 1:CAS:528:DC%2BD2MXht1Kjsbg%3D
-
Dresner-Pollak R, Ackerman Z, Eliakim R, et al. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet Test. 2004;8:417-420.
-
(2004)
Genet Test
, vol.8
, pp. 417-420
-
-
Dresner-Pollak, R.1
Ackerman, Z.2
Eliakim, R.3
-
19
-
-
0034323368
-
Bone mineral density in patients with recently diagnosed inflammatory bowel disease
-
11054377 10.1053/gast.2000.19280 1:STN:280:DC%2BD3M%2Fkt1yltQ%3D%3D
-
Schoon EJ, Blok BM, Geerling BJ, et al. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology. 2000;119:1203-1208.
-
(2000)
Gastroenterology
, vol.119
, pp. 1203-1208
-
-
Schoon, E.J.1
Blok, B.M.2
Geerling, B.J.3
|